Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Completed · Phase 2

Conditions studied: Lymphoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining doxorubicin and topotecan in treating patients who have relapsed or refractory intermediate-grade or high-grade non-Hodgkin's lymphoma.

Key facts

Study ID

NCT00006125

Run by

Alliance for Clinical Trials in Oncology

Starts

2000-07-01

Last updated by the study team

2016-07-14

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
• Veterans Affairs Medical Center - San Diego — San Diego, California, United States
• UCSF Comprehensive Cancer Center — San Francisco, California, United States
• Veterans Affairs Medical Center - San Francisco — San Francisco, California, United States
• CCOP - Christiana Care Health Services — Newark, Delaware, United States
• Lombardi Cancer Center — Washington D.C., District of Columbia, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• Veterans Affairs Medical Center - Washington, DC — Washington D.C., District of Columbia, United States
• Broward General Medical Center — Fort Lauderdale, Florida, United States
• Memorial Regional Hospital Comprehensive Cancer Center — Hollywood, Florida, United States
• CCOP - Mount Sinai Medical Center — Miami Beach, Florida, United States
• Florida Hospital Cancer Institute — Orlando, Florida, United States
• Helen and Harry Gray Cancer Institute at Good Samaritan Medical Center — West Palm Beach, Florida, United States
• Veterans Affairs Medical Center - Chicago (Westside Hospital) — Chicago, Illinois, United States
• University of Chicago Cancer Research Center — Chicago, Illinois, United States
• Louis A. Weiss Memorial Hospital — Chicago, Illinois, United States
• West Suburban Center for Cancer Care — River Forest, Illinois, United States
• Saint Anthony Medical Center — Rockford, Illinois, United States
• Fort Wayne Medical Oncology and Hematology, Incorporated — Fort Wayne, Indiana, United States
• Hematology Oncology Associates of the Quad Cities — Bettendorf, Iowa, United States
• Holden Comprehensive Cancer Center — Iowa City, Iowa, United States
• Baptist Hospital East - Louisville — Louisville, Kentucky, United States
• Marlene and Stewart Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland, United States
• Veterans Affairs Medical Center - Baltimore — Baltimore, Maryland, United States
• Northeast Alabama Regional Medical Center — Anniston, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.